Skip to main content
Top
Published in: Insights into Imaging 1/2023

Open Access 01-12-2023 | Cholangiocarcinoma | Original Article

Correlation analysis of MR elastography and Ki-67 expression in intrahepatic cholangiocarcinoma

Authors: Shanshan Gao, Wei Sun, Yunfei Zhang, Feihang Wang, Kaipu Jin, Xianling Qian, Jing Han, Xiaolin Wang, Yongming Dai, Ruofan Sheng, Mengsu Zeng

Published in: Insights into Imaging | Issue 1/2023

Login to get access

Abstract

Background

Intrahepatic cholangiocarcinoma (iCCA) is an aggressive primary liver cancer with dismal outcome, high Ki-67 expression is associated with active progression and poor prognosis of iCCA, the application of MRE in the prediction of iCCA Ki-67 expression has not yet been investigated until now. We aimed to evaluate the value of magnetic resonance elastography (MRE) in assessing Ki-67 expression for iCCA.

Results

In the whole cohort, 97 patients (57 high Ki-67 and 40 low Ki-67; 58 males, 39 females; mean age, 58.89 years, ranges 36–70 years) were included. At the multivariate analysis, tumor stiffness (odds ratio (OR) = 1.669 [95% CI: 1.307–2.131], p < 0.001) and tumor apparent diffusion coefficient (ADC) (OR = 0.030 [95% CI: 0.002, 0.476], p = 0.013) were independent significant variables associated with Ki-67. Areas under the curve of tumor stiffness for the identification of high Ki-67 were 0.796 (95% CI 0.702, 0.871). Tumor stiffness was moderately correlated with Ki-67 level (r = 0.593, p < 0.001). When both predictive variables of tumor stiffness and ADC were integrated, the best performance was achieved with area under the curve values of 0.864 (95% CI 0.780–0.926).

Conclusion

MRE-based tumor stiffness correlated with Ki-67 in iCCA and could be investigated as a potential prognostic biomarker. The combined model incorporating both tumor stiffness and ADC increased the predictive performance.

Critical relevance statement

MRE-based tumor stiffness might be a surrogate imaging biomarker to predict Ki-67 expression in intrahepatic cholangiocarcinoma patients, reflecting tumor cellular proliferation. The combined model incorporating both tumor stiffness and apparent diffusion coefficient increased the predictive performance.

Key points

• MRE-based tumor stiffness shows a significant correlation with Ki-67.
• The combined model incorporating tumor stiffness and apparent diffusion coefficient demonstrated an optimized predictive performance for Ki-67 expression.
• MRE-based tumor stiffness could be investigated as a potential prognostic biomarker for intrahepatic cholangiocarcinoma.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Bridgewater J, Galle PR, Khan SA et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268–1289CrossRefPubMed Bridgewater J, Galle PR, Khan SA et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268–1289CrossRefPubMed
2.
go back to reference Banales JM, Marin JJG, Lamarca A et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557–588CrossRefPubMedPubMedCentral Banales JM, Marin JJG, Lamarca A et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557–588CrossRefPubMedPubMedCentral
3.
go back to reference Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249CrossRefPubMed Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249CrossRefPubMed
4.
5.
go back to reference Jutric Z, Johnston WC, Hoen HM et al (2016) Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford) 18:79–87CrossRefPubMed Jutric Z, Johnston WC, Hoen HM et al (2016) Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford) 18:79–87CrossRefPubMed
6.
go back to reference Spolverato G, Kim Y, Alexandrescu S et al (2016) Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol 23:235–243CrossRefPubMed Spolverato G, Kim Y, Alexandrescu S et al (2016) Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol 23:235–243CrossRefPubMed
7.
go back to reference Spolverato G, Yakoob MY, Kim Y et al (2015) The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 22:4020–4028CrossRefPubMed Spolverato G, Yakoob MY, Kim Y et al (2015) The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 22:4020–4028CrossRefPubMed
8.
go back to reference Li S, Wu J, Huang O et al (2022) Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast Cancer. Front Oncol 12:833093CrossRefPubMedPubMedCentral Li S, Wu J, Huang O et al (2022) Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast Cancer. Front Oncol 12:833093CrossRefPubMedPubMedCentral
9.
go back to reference He J, Zhang C, Shi Q et al (2022) Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma. Comput Math Methods Med 2022:8367395CrossRefPubMedPubMedCentral He J, Zhang C, Shi Q et al (2022) Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma. Comput Math Methods Med 2022:8367395CrossRefPubMedPubMedCentral
10.
go back to reference Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 11:1566–1572CrossRefPubMed Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 11:1566–1572CrossRefPubMed
11.
go back to reference Hu XX, Yang ZX, Liang HY et al (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging 46:383–392CrossRefPubMed Hu XX, Yang ZX, Liang HY et al (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging 46:383–392CrossRefPubMed
12.
13.
go back to reference Rijken AM, Umezawa A, van Gulik TM et al (1998) Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma. Ann Surg Oncol 5:699–705CrossRefPubMed Rijken AM, Umezawa A, van Gulik TM et al (1998) Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma. Ann Surg Oncol 5:699–705CrossRefPubMed
14.
go back to reference Qiang Z, Zhang W, Jin S et al (2021) Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study. Ann Hepatol 20:100242CrossRefPubMed Qiang Z, Zhang W, Jin S et al (2021) Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study. Ann Hepatol 20:100242CrossRefPubMed
15.
16.
go back to reference Fan Y, Yu Y, Wang X, Hu M, Hu C (2021) Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma. BMC Med Imaging 21:100CrossRefPubMedPubMedCentral Fan Y, Yu Y, Wang X, Hu M, Hu C (2021) Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma. BMC Med Imaging 21:100CrossRefPubMedPubMedCentral
17.
go back to reference Glaser KJ, Manduca A, Ehman RL (2012) Review of MR elastography applications and recent developments. J Magn Reson Imaging 36:757–774CrossRef Glaser KJ, Manduca A, Ehman RL (2012) Review of MR elastography applications and recent developments. J Magn Reson Imaging 36:757–774CrossRef
18.
go back to reference Pepin KM, Ehman RL, McGee KP (2015) Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications. Prog Nucl Magn Reson Spectrosc 90–91:32–48CrossRefPubMed Pepin KM, Ehman RL, McGee KP (2015) Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications. Prog Nucl Magn Reson Spectrosc 90–91:32–48CrossRefPubMed
19.
go back to reference Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT (2017) American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 152:1544–1577CrossRefPubMed Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT (2017) American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 152:1544–1577CrossRefPubMed
20.
go back to reference Park SJ, Yoon JH, Lee DH, Lim WH, Lee JM (2021) Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection. J Magn Reson Imaging 53:587–596CrossRefPubMed Park SJ, Yoon JH, Lee DH, Lim WH, Lee JM (2021) Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection. J Magn Reson Imaging 53:587–596CrossRefPubMed
21.
go back to reference Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S (2005) Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 103:307–312CrossRefPubMed Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S (2005) Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 103:307–312CrossRefPubMed
22.
go back to reference Sofocleous CT, Garg S, Petrovic LM et al (2012) Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol 19:4262–4269CrossRefPubMedPubMedCentral Sofocleous CT, Garg S, Petrovic LM et al (2012) Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol 19:4262–4269CrossRefPubMedPubMedCentral
23.
go back to reference Hu X, Zhou J, Li Y, et al. (2022) Added Value of Viscoelasticity for MRI-Based Prediction of Ki-67 Expression of Hepatocellular Carcinoma Using a Deep Learning Combined Radiomics (DLCR) Model. Cancers 14(11):2575CrossRefPubMedPubMedCentral Hu X, Zhou J, Li Y, et al. (2022) Added Value of Viscoelasticity for MRI-Based Prediction of Ki-67 Expression of Hepatocellular Carcinoma Using a Deep Learning Combined Radiomics (DLCR) Model. Cancers 14(11):2575CrossRefPubMedPubMedCentral
24.
go back to reference Wang J, Shan Q, Liu Y et al (2019) 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence. J Magn Reson Imaging 49:719–730CrossRefPubMed Wang J, Shan Q, Liu Y et al (2019) 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence. J Magn Reson Imaging 49:719–730CrossRefPubMed
25.
go back to reference Song EJ, Sohn YM, Seo M (2018) Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer. Br J Radiol 91:20170830CrossRefPubMedPubMedCentral Song EJ, Sohn YM, Seo M (2018) Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer. Br J Radiol 91:20170830CrossRefPubMedPubMedCentral
26.
27.
go back to reference Gordic S, Ayache JB, Kennedy P et al (2017) Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol (NY) 42:1685–1694CrossRefPubMed Gordic S, Ayache JB, Kennedy P et al (2017) Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol (NY) 42:1685–1694CrossRefPubMed
28.
go back to reference Sirica AE, Gores GJ (2014) Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology 59:2397–2402CrossRefPubMed Sirica AE, Gores GJ (2014) Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology 59:2397–2402CrossRefPubMed
29.
go back to reference Cui X, Chen H, Cai S, Tang Q, Fang X (2019) Correlation of apparent diffusion coefficient and intravoxel incoherent motion imaging parameters with Ki-67 expression in extrahepatic cholangiocarcinoma. Magn Reson Imaging 63:80–84CrossRefPubMed Cui X, Chen H, Cai S, Tang Q, Fang X (2019) Correlation of apparent diffusion coefficient and intravoxel incoherent motion imaging parameters with Ki-67 expression in extrahepatic cholangiocarcinoma. Magn Reson Imaging 63:80–84CrossRefPubMed
30.
go back to reference Luo Y, Ren F, Liu Y et al (2015) Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int J Clin Exp Med 8:10235–10247PubMedPubMedCentral Luo Y, Ren F, Liu Y et al (2015) Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int J Clin Exp Med 8:10235–10247PubMedPubMedCentral
31.
go back to reference Settakorn J, Kaewpila N, Burns GF, Leong AS (2005) FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 58:1249–1254CrossRefPubMedPubMedCentral Settakorn J, Kaewpila N, Burns GF, Leong AS (2005) FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 58:1249–1254CrossRefPubMedPubMedCentral
Metadata
Title
Correlation analysis of MR elastography and Ki-67 expression in intrahepatic cholangiocarcinoma
Authors
Shanshan Gao
Wei Sun
Yunfei Zhang
Feihang Wang
Kaipu Jin
Xianling Qian
Jing Han
Xiaolin Wang
Yongming Dai
Ruofan Sheng
Mengsu Zeng
Publication date
01-12-2023
Publisher
Springer Vienna
Published in
Insights into Imaging / Issue 1/2023
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-023-01559-7

Other articles of this Issue 1/2023

Insights into Imaging 1/2023 Go to the issue